Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


14.08.2017

1 BMC Gastroenterol
1 Br J Cancer
1 Br J Surg
2 Eur J Cancer
1 Eur J Surg Oncol
1 Gut
1 Lancet Oncol
1 Oncol Rep
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. INAGAKI C, Suzuki T, Kitagawa Y, Hara T, et al
    A case report of prostate cancer metastasis to the stomach resembling undifferentiated-type early gastric cancer.
    BMC Gastroenterol. 2017;17:93.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. WENNERSTROM ECM, Simonsen J, Camargo MC, Rabkin CS, et al
    Acid-suppressing therapies and subsite-specific risk of stomach cancer.
    Br J Cancer. 2017;116:1234-1238.
    PubMed     Text format     Abstract available


    Br J Surg

  3. NELEN SD, van Putten M, Lemmens VEPP, Bosscha K, et al
    Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Br J Surg. 2017 Aug 9. doi: 10.1002/bjs.10621.
    PubMed     Text format     Abstract available


    Eur J Cancer

  4. FARAG S, Somaiah N, Choi H, Heeres B, et al
    Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients.
    Eur J Cancer. 2017;76:76-83.
    PubMed     Text format     Abstract available

  5. PETRELLI F, Tomasello G, Barni S
    Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers.
    Eur J Cancer. 2017;76:8-16.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  6. BUSWEILER LA, Henneman D, Dikken JL, Fiocco M, et al
    Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Eur J Surg Oncol. 2017 Jul 29. pii: S0748-7983(17)30589.
    PubMed     Text format     Abstract available


    Gut

  7. RAJENDRAN S, Benna C, Monticelli H, Spiro G, et al
    Germline variation of circadian pathway genes and prognosis of gastric cancer patients.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314740. doi: 10.1136/gutjnl-2017-314740.
    PubMed     Text format    


    Lancet Oncol

  8. THUSS-PATIENCE PC, Shah MA, Ohtsu A, Van Cutsem E, et al
    Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
    Lancet Oncol. 2017;18:640-653.
    PubMed     Text format     Abstract available


    Oncol Rep

  9. GUO J, Yan Y, Yan Y, Guo Q, et al
    Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
    Oncol Rep. 2017 Aug 3. doi: 10.3892/or.2017.5877.
    PubMed     Text format     Abstract available


    PLoS One

  10. CHENG S, Mao Q, Dong Y, Ren J, et al
    GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.
    PLoS One. 2017;12:e0182696.
    PubMed     Text format     Abstract available

  11. GU L, Chen M, Guo D, Zhu H, et al
    PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0182692.
    PubMed     Text format     Abstract available

  12. CAI J, Wang D, Bai ZG, Yin J, et al
    The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells.
    PLoS One. 2017;12:e0182433.
    PubMed     Text format     Abstract available

  13. NA HK, Cho CJ, Bae SE, Lee JH, et al
    Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma.
    PLoS One. 2017;12:e0169456.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: